Page 36

Business Unit Review

INTERNATIONAL BUSINESS continued United Kingdom and United States Region

2006

2005

R’million

R’million

Revenue

163

209

• Pharmaceuticals

157

204

6

5

EBITA

44

45

• Pharmaceuticals

43

45

1

• Consumer

• Consumer

ASPEN RESOURCES Consumer products added to the portfolio UK-based Aspen Resources, an intellectual property-owning and product-procurement company, raised EBITA by 12% to R41 million. In January 2006 the intellectual property portfolio was increased by the acquisition of a range of aerosol and roll-on deodorants from Reckitt Benckiser (Australia) Pty Ltd.

CO-PHARMA LTD A tough year in a difficult market The UK commodity generic market remained intensely competitive and Co-pharma Ltd (“Co-pharma”) reported a decline in revenue of 23% to R162 million and a reduction of 64% in EBITA to R3 million. Regrettably, little relief from the pricing pressure in this market is anticipated.

ASPEN USA Small beginnings Aspen USA Inc. (“Aspen USA”) was incorporated during the year. This operation is very much in its formative stage and is presently focused on exploring strategic opportunities in the USA market. No material trade took place during the year.

32

Aspen Annual Report 2006

Profile for Aspen Holdings

Aspen Annual Report 2006  

Aspen Annual Report 2006